Dr. Mamta Manglani

• MD (Pediatrics)
• DCH
• FRCPCH (UK)

• Former Director, MCGM - Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & Bone Marrow Transplantation Centre, Borivali (East), Mumbai
• Former Professor & Head, Department of Pediatrics, Lokmanya Tilak Municipal Medical College & General Hospital (LTMMC & LTMGH), Sion, Mumbai.
• Chief, Division of Pediatric Hematology-Oncology & Program Director, Pediatric Centre of Excellence for HIV Care, Lokmanya Tilak Municipal Medical College & General Hospital (Sion Hospital), Mumbai.

Dr. Manglani has authored and co-authored numerous national and international research papers, book chapters, and clinical studies on childhood cancers, thalassemia, bone marrow transplantation, and pediatric HIV.

1. Clinical, Genetic, and Immunological Spectrum of CHAI and LATAIE Patients from a Tertiary Referral Centre in India
2. Case Report - Acquired Pure Red Cell Aplasia in a Child
3. Klebsiella Pneumoniae Osteo- myelitis in Sickle Cell Anemia
4. Antenatal supplementation--effect on iron status of infants
5. Evaluation of naked eye single tube osmotic fragility test in detecting beta-thalassemia trait
6. Askin Rosai tumor.
7. Klebsiella pneumoniae osteomyelitis in sickle cell anemia
8. Successful treatment with cyclophosphamide in a large hepatic hemangioendothelioma
9. Current role of intravenous gammaglobulin
10. NESTROFT'--an effective screening test for beta thalassemia trait
11. Intussusception in an Infant With Acute Lymphoblastic Leukemia
12. Anemia in Newborn
13. Congenital Erythrocytosis With Elevated Erythropoietin Level
14. Intussusception in an infant with acute lymphoblastic leukemia: A case report and review of the literature
15. Leukemic transformation in Fanconi's anemia
16. Congenital factor V deficiency - A case report
17. Toxicity study of pegaspargase
18. Clinical spectrum of HIV infection
19. Acquired pure red cell aplasia in a child
20. Chapter-09 Bone Marrow Failure Syndromes in the Neonate
21. Diamond-Blackfan Anemia: Report of 6 Cases
22. Prevention of mother to child transmission of HIV
23. Griscelli syndrome: A case report
24. Effect of deferiprone on urinary zinc excretion in multiply transfused children with thalassemia major
25. Rational use of blood components - An audit
26. Pseudomonas diarrhea in a child suffering from acute lymphatic leukemia
27. All Trans Retinoic Acid (ATRA) induced myositis
28. Isolation of Streptobacillus moniliformis from the blood of a child with acute lymphoblastic leukaemia
29. Assessment of safety and immunogenicity of two different lots of diphtheria,tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process
30. Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process
31. Hidradenitis suppurativa in a HIV-infected child
32. Correspondence
33. Acute glomerulonephritis in dengue haemorrhagic fever in the absence of shock, sepsis, haemolysis or rhabdomyolysis
34. Deferiprone is Superior to Deferasirox and Desferrioxamine in Cardiac Iron Overload.
35. Antiretroviral Therapy in Children: Recent Advances
36. Hematological Manifestations in Parvovirus Infection
37. Poor Outcomes in a Cohort of HIV-Infected Adolescents Undergoing Treatment for Multidrug-Resistant Tuberculosis in Mumbai, India
38. Multicenter prospective surveillance of invasive pnuemococcal disease in children (<5 years) from Maharashtra, India.
39. Guidelines for screening, diagnosis and management of Hemoglobinopathies
40. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-DT): A Multicenter, Open-label, Non-randomized, Phase III Clinical Trial
41. Alarming Levels of Drug-Resistant Tuberculosis in HIV-Infected Patients in Metropolitan Mumbai, India
42. Immunoglobulin levels and CD4 / CD8 counts in β — Thalassemia major
43. Chapter-05 Blood Dyscrasias and Anesthesia in Children
44. Molecular characterization of leukocyte adhesion deficiency-I in Indian patients: Identification of 9 novel mutations
45. Human Vaccines & Immunotherapeutics A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine
46. 21645515.2015
47. A comparative clinical study to assess safety and reactogenicity of a DTPw-HepB+Hib vaccine (vol 11, pg 901, 2015)
48. Source of factor VIII replacement (PLASMATIC OR RECOMBINANT) and incidence of inhibitory alloantibodies in previously untreated patients with severe hemophilia A: the multicenter randomized sippet study
49. Prevalence of pulmonary hypertension in children with sickle cell disease
50. Chapter-17 Thalassemia Syndromes
51. Chapter-11 Bleeding Neonate: Approach and Management
52. Isolated conjunctival mass presenting as acute myeloid leukemia in an infant
53. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
54. Building Developmental-Behavioral Pediatrics in Low-Middle Income Countries Through International Collaboration
55. Clinical, Immunological, and Molecular Findings of Patients with p47phox Defect Chronic Granulomatous Disease (CGD) in Indian Families
56. To study the factors affecting quality of life in children suffering from hemophilia
57. Is serum ferritin a reliable marker for evaluation of cardiac and hepatic iron overload in patients with β-thalassemia major?
58. To study the factors affecting quality of life in children suffering from hemophilia
59. Hematopoietic stem cell transplantation in a public hospital – Our experience
60. Chapter-058 Approach to a Child with Persistent Anemia
61. A study of the adverse drug reactions of L-asparaginase in newly diagnosed children with acute lymphoblastic leukemia
62. Autoimmune complication post HSCT in a case of MDS with monosomy 7
63. Palliative care and Pediatric HIV
64. Prospective Study of Impact of Feeding Practices on the Growth, Development and Infections in HIV Exposed Infants versus HIV non-exposed Infants.
65. Prospective Study of Impact of Feeding Practices on the Growth, Development and Infections in HIV Exposed Infants versus HIV non-exposed Infants.
66. Acquired methemoglobinemia–A sporadic Holi disaster
67. A study of clinical spectrum of opportunistic infections in HIV infected children and its correlation with CD4 count and anti-retroviral therapy
68. Adherence to antiretroviral therapy and factors affecting adherence among paediatric HIV patients
69. Management of ß-thalassemia – Consensus and controversies!
70. HLA- B*5701 Allele in HIV-infected Indian Children and its Association with Abacavir Hypersensitivity
71. A Rare Immunodeficiency Disorder Masquerading As Auto-Immune Hemolytic Anemia
72. The Genes Speak - A Rare Case of Hemolytic Anemia!
73. Common Mutations of β-Thalassemia – A Changing Arena!
74. Counselling in Thalassemia – Encompassing Comprehensive Care!
75. Familial Hemophagocytic Lymphohistiocytosis (Fhl) – A Case Series
76. Thalassemia: Impact of Physiotherapy
77. Pediatric Cml, A Rare Entity With Diagnostic And Therapeutic Challenges: Case Reports
78. Out-of-pocket expenditure incurred by families of children newly diagnosed with cancer in India prior to start of treatment – First report of a multi-site prospective study
79. Families of Children Newly Diagnosed With Cancer Incur Significant Out-of-Pocket Expenditure for Treatment: Report of a Multi-Site Prospective Longitudinal Study From India (INPOG-ACC-16-01)
80. Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study
81. Pancytopenia In Infancy – A Reflection Of Defective Gene (Mysm1 Deficiency: An Orphan Entity)
82. To Study Renal Dysfunction In Children And Adolescents With Thalassemia Major
83. Aplastic Anaemia- Delving Into The Genes
84. Peripheral Smear Examination: More Than Window Into The Hematopoietic System
85. To Study Renal Dysfunction In Children And Adolescents With Thalassemia Major
86. Hearing loss with oral chelators in thalassemia
87. Molecular genotyping of clinically important blood group antigens in patients with thalassaemia
88. Red cell adenylate kinase deficiency in India: Identification of two novel missense mutations (c.71A>G and c.413G>A)
89. Impact of Anemia on Outcome of HIV-Infected Pediatric Patients: A Prospective Observational Study
90. Indigenously Prepared Ready-to-use Therapeutic Food (RUTF) in Children with Severe Acute Malnutrition
91. Can telemedicine initiative be an effective intervention strategy for improving treatment compliance for pediatric HIV patients: Evidences on costs and improvement in treatment compliance from Maharashtra, India
92. Guidance for Pediatric Hematology-Oncology (PHO) and Hematopoietic Stem Cell Transplant Services during COVID-19 Pandemic: A Consensus Statement by PHO Chapter of Indian Academy of Pediatrics
93. Upfront use of plerixafor and G-CSF with large-volume (LVL) apheresis in pediatric autologous stem cell transplants
94. To study outcome of patients previously exposed to steroids with treatment naïve in paediatric acute lymphoblastic leukemia (ALL) in a tertiary care centre
95. Mercaptopurine (6-MP) induced symptomatic hypoglycemia: A rare side effect!
96. Prevalence of TPMT/ MTHFR/ RFC/NUDT15 gene polymorphisms and effect on 6-mercaptopurine & methotrexate dosage in Indian children with acute lymphoblastic leukemia
97. Pediatric MDS: More than meets the eye
98. A study of anti-oxidant levels pre and post induction chemotherapy in children with acute lymphoblastic leukemia
99. Current scenario of pediatric brain tumors in a developing country: A single center study
100. A clinical profile of early T cell precursor all in a tertiary care centre
101. Vanishing catheter – Fracture at exit with migration of entire PICC!
102. Neurotoxicity with vinca alkaloids- A retrospective observational study at a tertiary care center
103. Reaching the Unreached: Providing Quality Care to HIV-Infected Children through Telemedicine—An Innovative Pilot Initiative from Maharashtra, India
104. IntJPed
105. Clinical and Genetic Spectrum of a Large Cohort of Patients With Leukocyte Adhesion Deficiency Type 1 and 3: A Multicentric Study From India
106. Assessing the Effectiveness of a Telemedicine Initiative in Clinical Management of Children Living with HIV/AIDS in Maharashtra, India
107. Vitamin C Deficiency and Oxidant Levels in Children With Transfusion-Dependent β-Thalassemia
108. Pediatric Blood & Cancer Efficacy of ready-to-use therapeutic food in malnourished children with cancer: Results of a randomized, open-label phase 3 trial
109. Comprehensive molecular study identified 12 complementation groups with 56 novel FANC gene variants in Indian Fanconi anemia subjects
110. Hematopoietic stem cell transplant (HSCT) in transfusion dependent thalassemia – Experience of a public sector hospital in Mumbai
111. Haploidentical stem cell transplantation of paediatric hematolymphoid conditions - An experience from a public sector hospital
112. Outcomes of COVID-19 in children with cancer – Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India
113. Attitudes and acceptability of children, caregivers, and healthcare providers about using telemedicine for pediatric HIV care in a resource-limited setting
114. TO STUDY RENAL DYSFUNCTION IN CHILDREN AND ADOLESCENTS WITH THALASSEMIA MAJOR
115. Diagnosis, Treatment and Prevention of Nutritional Anemia in Children: Recommendations of the Joint Committee of Pediatric Hematology-Oncology Chapter and Pediatric and Adolescent Nutrition Society of the Indian Academy of Pediatrics
116. PROGNOSTIC VARIABLES AND OUTCOME OF HIGH-RISK NEUROBLASTOMA TREATED IN A TERTIARY CANCER CENTRE IN INDIA.
117. Prenatal diagnosis of thalassemia: A cost-effective step towards eradication
118. Autologous hematopoietic stem cell transplant in pediatric lymphoma our experience
119. Fluconazole as primary antifungal prophylaxis for pediatric hematopoietic stem cell transplant in antifungal NA ÆVE patients
120. Inherited thrombocytopenias: Early diagnosis for optimum treatment
121. Matched unrelated donor hematopoietic stem cell transplant in a child with chronic myeloid leukemia
122. Sirolimus as immunosuppressive agent in pediatric allogenic hematopoetic transplant recipients
123. Therapeutic outcomes of severe aplastic anemia: The earlier the better!
124. Spectrum of patients with hemoglobin E-B thalassemia and their response to hydroxyurea - Experience of a single centre
125. Allogenic HSCT in primary immunodeficiency disorder: A hope to cure
126. Sclerotic GVHD: an uncommon complication in children post HSCT - A case report
127. Survey to assess the quality of services available for thalassemia diagnosis and management in India
128. Ruxolitinib- A hope for steroid refractory chronic GVHD manifesting as nephrotic syndrome
129. Maternal-Fetal Iron Kinetics
130. PB2431: OUTCOME OF HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE APLASTIC ANEMIA IN PEDIATRIC POPULATION - A SINGLE CENTER EXPERIENCE FROM PUBLIC HOSPITAL
131. Efficacy of Low Dose Vs Standard Dose of Thalidomide in Patients with Transfusion-Dependent Thalassemia (TDT): A Non-Inferiority Trial
132. Real-world outcomes of children treated for high-risk neuroblastoma and the challenge in identifying the ultra-high-risk
133. Impact of high-risk factors on the outcomes of HSCT in children with acquired severe aplastic anaemia
134. Thrombotic Microangiopathy in children: Redefining HUS, TTP and related disorders!
135. The Indian Academy of Pediatrics and Directorate General of Health Services, Government of India White Paper on Transition of Care for Youth with Special Health Care Needs
136. Association of TGF-β1 -509 C > T (rs1800469) polymorphism with bone marrow failure severity in Fanconi anemia subjects
137. Assessment of services for diagnosis, management and prevention of thalassaemia in India: The way forward.